Oxaliplatin plus gemcitabine as a salvage schedule for hormone-refractory prostate adenocarcinoma

Clinical and Translational Oncology

Volumn 10, Issue 6, 2008, Pages 372-374

  Eslava Santisteban, Marta ^a   Pérez Gracia, José Luis ^a   Ceballos, Jaime ^a   Vivas, Isabel ^a   García Foncillas, Jesús ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Gemcitabine; Hormone refractory; Oxaliplatin; Prostate carcinoma

Indexed keywords

ANTIANDROGEN; DOCETAXEL; ESTRAMUSTINE; ETOPOSIDE; GEMCITABINE; OXALIPLATIN; PROSTATE SPECIFIC ANTIGEN; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; PLATINUM COMPLEX;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; ANOREXIA; ARTICLE; ASTHENIA; BONE METASTASIS; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; GLEASON SCORE; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; ORCHIECTOMY; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; TREATMENT OUTCOME; WEIGHT REDUCTION; ADENOCARCINOMA; BLOOD; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROSTATE TUMOR; SALVAGE THERAPY; TUMOR RECURRENCE;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEOXYCYTIDINE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 51649124729     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-008-0214-9     Document Type: Article

References (7)

1. Petrylak DP, Tangen CM, Hussain MH et al (2004) Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 351:1513-1152
2. Tannock IF, de Wit R, Berry WR et al (2004) Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 351:1502-1512
3. Droz JP, Muracciole X, Mottet N et al (2003) Phase II study of oxaliplatin versus oxaliplatin combined with infusional 5-fluorouracil in hormone refractory metastatic prostate cancer patients. Ann Oncol 14:1291-1298
4. Di Lorenzo G, Autorino R, Giuliano M et al (2007) Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer. Urology 69:347-351
5. Qin ZK, Yang GW, Zhou FJ et al (2004) Short-term efficacy of combined chemotherapy of gemcitabine and cisplatin on advanced hormone refractory prostate cancer. Ai Zheng 23:1700-1703
6. Inoue S, Oka K, Araki T et al (2007) Neuroendocrine carcinoma of the prostate effectively treated by cisplatin and irinotecan-a case report. Gan To Kagaku Ryoho 34:1323-1325
7. Feinstein T, Appleman LJ, Friedland DM et al (2007) A phase II trial of oxaliplatin and docetaxel in patients with androgen independent prostate cancer (AIPC) who have progressed to two prior regimens of chemotherapy. J Clin Oncol, ASCO Annual Meeting Proceedings Part I 25(18S).